Crossmark

Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report

Crossref DOI link: https://doi.org/10.1186/s12885-018-4116-0

Published Online: 2018-02-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiao, Xiao-Dong

Ding, Chunming

Zang, Yuan-Sheng

Yu, Guanzhen
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81572856)

Shanghai Pujiang Program (13PJD002)

International Science and Technology Cooperation Program of China (2014DFA33010)

Young Start-up Foundation of Changzheng Hospital (2015CZQN07)

Shanghai Municipal Health and Family Planning Commission Foundation (201540174)
More Information

Article History

Received: 12 December 2016

Accepted: 9 February 2018

First Online: 20 February 2018

Ethics approval and consent to participate

: The institutional review boards of the Changzheng Hospital approved this study.

: The informed consent was obtained from the patient’s guardian (father).

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.